Revolution Medicines Inc [RVMD] stock is trading at $70.87, up 1.42%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The RVMD shares have gain 4.61% over the last week, with a monthly amount glided 32.62%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Revolution Medicines Inc [NASDAQ: RVMD] stock has seen the most recent analyst activity on November 18, 2025, when Wolfe Research initiated its Outperform rating and assigned the stock a price target of $75. Previously, RBC Capital Mkts started tracking the stock with Outperform rating on November 03, 2025, and set its price target to $77. On October 21, 2025, Mizuho initiated with an Outperform rating and assigned a price target of $90 on the stock. Truist started tracking with a Buy rating for this stock on September 05, 2025, and assigned it a price target of $99. In a note dated August 19, 2025, Piper Sandler initiated an Overweight rating and provided a target price of $75 on this stock.
Revolution Medicines Inc [RVMD] stock has fluctuated between $29.17 and $72.72 over the past year. Currently, Wall Street analysts expect the stock to reach $82 within the next 12 months. Revolution Medicines Inc [NASDAQ: RVMD] shares were valued at $70.87 at the most recent close of the market. An investor can expect a potential return of 15.7% based on the average RVMD price forecast.
Analyzing the RVMD fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.43, Equity is -0.49 and Total Capital is -0.52. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 69.59 points at the first support level, and at 68.31 for the second support level. However, for the 1st resistance point, the stock is sitting at 72.06, and for the 2nd resistance point, it is at 73.25.
Ratios To Look Out For
For context, Revolution Medicines Inc’s Current Ratio is 8.05. Also, the Quick Ratio is 8.05, while the Cash Ratio stands at 0.89.
Transactions by insiders
Recent insider trading involved GOLDSMITH MARK A, that happened on Nov 18 ’25 when 20000.0 shares were sold. General Counsel, Cislini Jeff completed a deal on Nov 18 ’25 to sell 13388.0 shares. Meanwhile, Director MARK A GOLDSMITH bought 20000.0 shares on Nov 18 ’25.
